Neomycin Sulfate, Polymyxin B Sulfate And Dexamethasone Suspension
Product Images NDC 69918-515

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neomycin Sulfate, Polymyxin B Sulfate And Dexamethasone (NDC 69918-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nordic Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neomycin Sulfate (Neomycin 01)

Chemical structure diagram of dexamethasone, one of the active ingredients in neomycin sulfate, polymyxin b sulfate, and dexamethasone ophthalmic suspension.*

FDA Label Image

The Structural Formula For Neomycin Sulfate (Neomycin 02)

Chemical structure diagram of neomycin sulfate, indicated by its characteristic sugar-based rings and multiple amino groups, shown with a sulfate ion (H2SO4) as part of the compound.*

FDA Label Image

The Structural Formula For Polymyxin B Sulfate (Neomycin 03)

Chemical structure diagram displaying the synthesis pathway of 2,4-diaminobutyric acid (DAB) and a table listing structural variations (R, R', X) for polymyxin B1, B2, B3, and B1-I. The diagram includes chemical intermediates and reagents such as L-DAAB and L-Thr with sulfuric acid noted.*

FDA Label Image

Neomycin-05.jpg (Neomycin 04)

Packaging label for Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, 5 mL, by Nordic Pharma, Inc. The label includes active ingredient strengths, storage instructions, precautionary warnings, and manufacturer details. The design features the Nordic Pharma logo and a barcode, with text indicating the product is sterile and for topical ophthalmic use only.*

FDA Label Image

Neomycin-05.jpg (Neomycin 05)

Label for neomycin sulfate, polymyxin b sulfate and dexamethasone ophthalmic suspension. The product is indicated as Rx only and supplied in a sterile 5 mL bottle. Label includes active ingredient concentrations, storage instructions (store at 8-27°C), and manufacturer information for Nordic Pharma, Inc. The NDC number 69918-515 is displayed prominently.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.